The Anthem Public Policy Institute was established to share data and insights to inform public policy and shape the health care programs of the future. The Public Policy Institute strives to be an objective and credible contributor to health care innovation and transformation through publication of policy-relevant data analysis, timely research, and insights from Anthem’s innovative programs.
Enhanced Consumer Engagement and Decision-Making Are Driving Better Health
July - 2016
Following the passage of the Affordable Care Act (ACA), states have taken different approaches to Medicaid reform and expansion. One state pursued Medicaid reform under its state-specific model by incorporating unique aspects such as personal responsibility and building on the success of its pre-ACA model. The Medicaid model uses program and benefit design, along with both financial and non-financial incentives, to drive consumer engagement and decision-making. A new white paper from Anthem's Public Policy Institute details promising initial results from this new model in Medicaid.
Early Results from the Enhanced Personal Health Care Program: Learning for the Movement to Value-Based Payment
Mar - 2016
The Enhanced Personal Health Care program was created to build upon the success of patient-centered and value-based care, which research has shown is capable of delivering higher quality and more affordable care for patients. A new report from the Anthem Public Policy Institute shares the company’s learnings from the early stages of this effort which includes partnerships with 54,000 providers serving more than 4.6 million patients as of the end of 2015.
Facilitating Open Communication About Emerging Therapies
Jan - 2016
Anthem and Eli Lilly and Company have come together to suggest major public policy solutions to help spur innovation towards tying drug pricing to value including allowing for more robust communication between health plans and drug makers before a drug is approved.
Promoting Value-Based Contracting Arrangements
Jan - 2016
Anthem and Eli Lilly and Company have come together to suggest major public policy solutions to help spur innovation towards tying drug pricing to value including addressing two of the most significant legal and regulatory barriers that prohibit value-based payment arrangements.
Hidden Benefits: The Value of Medicaid Managed Care
Sept - 2015
As states increasingly look to risk-based managed care to serve the majority of Medicaid beneficiaries, they are also looking for new and innovative ways to ensure that beneficiaries have access to the full array of services needed to keep them healthy. Traditional measures of “network adequacy” – including physician-to-enrollee ratios and time/distance requirements – are important, but they paint an incomplete picture of how Medicaid managed care plans, working with their provider and state partners, enhance network access and delivery of high quality care for their members through innovative network-enhancing strategies.